Masao Matsuoka Selected Research

Transforming Growth Factor beta (TGF-beta)

1/2009	SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells.
4/2004	Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masao Matsuoka Research Topics

Disease

37	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 11/2023 - 01/2002
29	Infections 01/2023 - 04/2002
19	T-Cell Leukemia (Leukemia, T Cell) 01/2023 - 08/2002
19	Neoplasms (Cancer) 01/2023 - 06/2003
10	Lymphoma (Lymphomas) 06/2022 - 06/2003
8	Carcinogenesis 12/2018 - 08/2005
7	Multiple Myeloma 10/2022 - 01/2019
4	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 08/2002
4	Inflammation (Inflammations) 01/2020 - 08/2015
4	HIV Infections (HIV Infection) 12/2019 - 04/2002
4	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 01/2018 - 08/2002
3	Amyloidosis 05/2023 - 01/2022
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 07/2017
3	COVID-19 01/2023 - 01/2022
3	Spinal Cord Diseases 01/2019 - 08/2002
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 01/2023
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2023 - 05/2022
2	Immunoglobulin Light-chain Amyloidosis 10/2022 - 11/2021
2	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2022 - 07/2021
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022 - 08/2002
2	Virus Diseases (Viral Diseases) 11/2012 - 09/2012
1	Pneumonia (Pneumonitis) 12/2023
1	Disease Progression 11/2023
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2023
1	Hepatitis B 10/2023
1	Dermatomyositis (Dermatopolymyositis) 01/2023
1	Communicable Diseases (Infectious Diseases) 01/2023
1	Polymyositis 01/2023
1	Heart Failure 10/2022

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 10/2023 - 11/2007
7	Messenger RNA (mRNA)IBA 01/2022 - 01/2006
6	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2006
5	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2010
5	CytokinesIBA 01/2020 - 08/2002
5	LigandsIBA 01/2019 - 09/2006
4	NucleosidesIBA 01/2022 - 01/2007
4	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2008
4	6H- 6- imino- (2,3,4,5- tetrahydropyrimido)(1,2- c)- (1,3)benzothiazineIBA 04/2015 - 09/2012
4	DNA (Deoxyribonucleic Acid)IBA 12/2009 - 04/2004
3	EnzymesIBA 01/2023 - 01/2008
3	mogamulizumabIBA 03/2022 - 01/2018
3	ParaffinIBA 01/2022 - 11/2016
3	Bortezomib (Velcade)FDA Link 11/2021 - 07/2004
3	Macrophage Colony-Stimulating FactorIBA 01/2019 - 01/2002
3	IminesIBA 04/2015 - 11/2012
3	Reverse Transcriptase InhibitorsIBA 12/2009 - 11/2006
2	AntibodiesIBA 01/2023 - 04/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 03/2006
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 09/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022 - 01/2022
2	Lenalidomide (CC 5013)FDA Link 10/2022 - 01/2022
2	daratumumabIBA 10/2022 - 01/2022
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 05/2022 - 01/2020
2	VaccinesIBA 01/2022 - 05/2015
2	Formaldehyde (Formol)FDA Link 01/2022 - 01/2019
2	fludarabineIBA 07/2021 - 08/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 08/2002
2	Cell Adhesion Molecule-1IBA 12/2018 - 07/2017
2	InterleukinsIBA 01/2018 - 08/2002
2	Immune Checkpoint ProteinsIBA 07/2017 - 11/2016
2	Immunoglobulins (Immunoglobulin)IBA 07/2017 - 11/2016
2	MucinsIBA 07/2017 - 11/2016
2	Anti-HIV Agents (AIDS Drugs)IBA 10/2015 - 04/2002
2	InterferonsIBA 10/2015 - 08/2015
2	pyrimidineIBA 04/2015 - 04/2015
2	Anti-Retroviral Agents (Antiretroviral Agents)IBA 04/2015 - 11/2012
2	Oncogene Proteins (Oncogene Protein)IBA 04/2015 - 04/2007
2	Zidovudine (Retrovir)FDA LinkGeneric 04/2013 - 11/2006
2	Tenofovir (Viread)FDA Link 04/2013 - 11/2006
2	Peptides (Polypeptides)IBA 12/2010 - 01/2008
2	AntigensIBA 08/2009 - 04/2002
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2009 - 04/2004
2	Viral ProteinsIBA 08/2005 - 08/2003
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2023
1	Capsid Proteins (Capsid Protein)IBA 10/2023
1	Viral DNAIBA 10/2023
1	Circular DNAIBA 10/2023
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 05/2023
1	Coloring Agents (Dyes)IBA 03/2023
1	Ligases (Synthetase)IBA 01/2023
1	cilgavimabIBA 01/2023
1	Inosine FDA Link 01/2023
1	Core Binding Factors (Core-Binding Factor)IBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	Adenosine (Adenocard)FDA LinkGeneric 01/2023
1	tixagevimabIBA 01/2023
1	Monoclonal AntibodiesIBA 10/2022
1	Amyloid (Amyloid Fibrils)IBA 10/2022
1	CholesterolIBA 06/2022
1	PD 128042IBA 06/2022
1	LipidsIBA 06/2022

Therapy/Procedure

13	Therapeutics 12/2023 - 04/2002
7	Drug Therapy (Chemotherapy) 05/2023 - 11/2011
4	Hematopoietic Stem Cell Transplantation 01/2023 - 06/2008
2	Transplantation 11/2022 - 07/2021
2	Immunotherapy 07/2017 - 11/2016
2	Molecular Targeted Therapy 06/2014 - 11/2011
2	Highly Active Antiretroviral Therapy (HAART) 01/2008 - 04/2002
1	Cell Transplantation 03/2022